Healthcare-associated infections (HAIs) cost lives, extend hospital stays, and place enormous strain on healthcare systems. As facilities search for more powerful tools to complement traditional cleaning and disinfection practices, one technology has emerged as a significant area of both investment and debate: UV-C disinfection.
Used in operating rooms, patient wards, ICUs, and even mobile robotics applications, UV-C light is increasingly woven into modern infection prevention strategies. But the science behind it is more nuanced than its marketing often suggests — and understanding that nuance is essential for any healthcare facility considering adoption.
This article examines how UV-C disinfection works, what the evidence says about its effectiveness, where it fits within a comprehensive IPAC program, and what practical steps facilities should take before deploying it.
What Is UV-C Disinfection and How Does It Work
UV-C refers to ultraviolet light in the wavelength range of 100 to 280 nanometers. Within this range, wavelengths around 254 nm have been most widely used for germicidal applications, while emerging “far UV-C” technology at 222 nm is gaining significant attention for its potential use in occupied spaces.
UV-C stands for Ultraviolet C radiation, a portion of the electromagnetic spectrum with wavelengths between 100 and 280 nanometers. This high-energy light is known for its germicidal properties and is capable of inactivating DNA and RNA molecules in microorganisms, effectively killing bacteria, viruses, fungi, and other pathogens. When harmful microorganisms come into contact with UV-C radiation, they undergo rapid denaturation of their genetic material, rendering them unable to reproduce.
This mechanism is fundamentally different from chemical disinfectants, which work through oxidation or cell membrane disruption. UV-C’s direct attack on genetic material means that pathogens cannot develop genetic resistance to it in the same way they do with antimicrobial agents — a significant advantage in an era of increasing antimicrobial resistance.
The effectiveness of UV-C depends on factors such as intensity, exposure time, and distance from the light source. These physical variables must be carefully managed to ensure reliable disinfection outcomes.
The Market and Regulatory Landscape
UV-C technology has experienced rapid market growth, particularly following the COVID-19 pandemic, which accelerated adoption of no-touch disinfection technologies across healthcare and public-facing sectors.
The global UV-C disinfection product market is projected to expand from USD 12.66 billion in 2025 to USD 39.64 billion by 2035, reflecting a compound annual growth rate of 12.1%, driven by increasing global awareness of hygiene and infection control across healthcare, commercial, and residential sectors.
Regulatory oversight of UV-C devices in healthcare settings is also evolving. On September 1, 2023, the FDA granted Xenex’s LightStrike+ Whole Room Microbial Reduction Device a De Novo classification, establishing that such devices require FDA authorization to ensure safety and effectiveness in clinical settings.
This regulatory shift has significant implications. FDA clearance should now be a baseline requirement when healthcare leaders and infection preventionists evaluate UV-C technologies. The vast majority of products on the market lack this clearance and may be subject to FDA enforcement action.
For Canadian facilities, the equivalent principle applies: verify that any UV-C technology you adopt meets Health Canada’s device regulatory requirements and has supporting clinical evidence for its stated disinfection claims.
What the Evidence Says: Strengths and Limitations
The evidence base for UV-C disinfection is substantial but complex. Understanding both the benefits and limitations prevents over-reliance on technology at the expense of proven fundamental practices.
Where UV-C Shows Strong Evidence
Research demonstrates that a surface exposure of approximately 2,200 mJ/cm² over 20 minutes can inactivate nearly 100% of C. difficile spores. A comprehensive review in the Journal of Hospital Infection reports that combining continuous UV-C with pulsed-xenon UV (PX-UV) systems achieves a reduction of up to 70% in infection rates for pathogens such as C. difficile and MRSA, and is most effective when used in conjunction with manual cleaning.
Ultraviolet light disinfection technologies have demonstrated potential in reducing HAIs, particularly when integrated into a comprehensive infection prevention strategy. Their effectiveness varies by application, pathogen type, and healthcare setting.
UV-C is particularly valuable as a terminal disinfection tool — applied after patient discharge or transfer to reduce the environmental burden of pathogens before the next patient occupies the space. It performs a disinfection task that human cleaning alone cannot reliably replicate for every discharge.
Where UV-C Shows Limitations
No technology is without limitations, and UV-C is no exception.
UV-C disinfection relies on direct line-of-sight exposure to effectively kill microorganisms. Inadequately exposed surfaces — those in shadow, behind equipment, or at angles away from the UV-C source — may experience incomplete disinfection.
Organic matter on surfaces significantly reduces UV-C effectiveness. This is why UV-C should always follow thorough manual cleaning, never replace it.
UV-C disinfection should currently be considered for low-level rather than high-level disinfection unless device specifications and in-setting validation support higher performance claims. Multiple factors are detrimental to disinfection performance including shadowing, rough surface topography, high contamination levels, and lack of standardization across devices.
Healthcare facilities should approach UV-C as a powerful supplementary tool, not a replacement for manual cleaning, hand hygiene, and other foundational IPAC measures.
Applications of UV-C in Healthcare Settings
UV-C disinfection solutions are being implemented across multiple areas of healthcare facilities, including air purification systems installed in HVAC systems to continuously clean air throughout the facility, surface disinfection for high-touch items like doorknobs and bed rails, water treatment systems to prevent Legionella outbreaks, and operating rooms to reduce post-operative infections.
Patient Room Terminal Disinfection
This is the most widely validated application. After a patient with a known or suspected HAI pathogen is discharged, a UV-C device is deployed in the vacated room to provide a no-touch terminal disinfection cycle. This supplements the manual clean conducted by environmental services staff.
The sequential workflow is: thorough manual cleaning first, then UV-C deployment, with the room locked to prevent entry during the cycle. Positioning the UV-C device to minimize shadow areas is essential — this typically requires multiple device positions within the same room.
Intensive Care Units and High-Risk Wards
ICUs house the most immunocompromised patients in the facility and carry the highest HAI rates. UV-C technology in ICU settings has shown measurable reductions in pathogen burden on surfaces when deployed systematically as part of a structured environmental hygiene protocol.
For facilities managing MRSA in high-acuity settings, the MRSA in long-term care resource outlines the broader infection control framework into which UV-C technology fits as a supplementary tool.
Air Disinfection via HVAC Integration
UV-C air purification systems installed in HVAC infrastructure can continuously clean air circulating throughout the facility. This application is particularly relevant for respiratory pathogen control in settings with high patient volumes or inadequate natural ventilation.
Upper-room UV-C systems, which irradiate the upper zone of occupied rooms while leaving the lower breathing zone unaffected, are another emerging application for settings where continuous in-room disinfection is desired without room evacuation.
Far UV-C (222 nm) Technology
Far UV-C represents the most exciting recent development in this field. Unlike traditional UV-C at 254 nm, which can be harmful to human skin and eyes, 222 nm wavelengths do not penetrate the outer layers of the skin or the tear layer of the eye, making them a safer alternative for continuous use in populated healthcare spaces. A recent systematic review confirmed that 222 nm UV-C delivers disinfection results comparable to 254 nm UV-C across a broad range of microorganisms.
This safety profile opens the possibility of using UV-C continuously in occupied spaces — a transformative potential application for high-traffic areas such as waiting rooms, corridors, and clinical consultation areas.
Safety Considerations for Healthcare Staff
Conventional UV-C at 254 nm is a significant occupational health hazard. Direct exposure causes photokeratitis (a painful eye injury comparable to a corneal sunburn) and erythema (skin burns). Staff must never be present in a room during a UV-C cycle.
Implement strict lockout-tagout procedures for all UV-C equipment deployments. Use physical barriers, signage, and door sensors to prevent accidental entry. All staff who operate or work near UV-C equipment must receive documented safety training.
Motion sensors that automatically shut down the UV-C cycle when movement is detected are a valuable safety feature — consider this a minimum requirement for any automated UV-C device deployed in your facility.
Proper installation and maintenance are crucial for effectiveness. Some materials may be damaged by UV-C light, requiring careful selection of surfaces. Staff training is essential to ensure safe handling and operation of UV-C equipment. Regular testing and validation of systems is necessary to maintain efficacy.
Integrating UV-C into Your IPAC Program
UV-C is most effective when embedded within a comprehensive, multi-layered IPAC strategy rather than deployed as a standalone solution.
The foundation remains unchanged: rigorous hand hygiene, appropriate PPE use, standard and transmission-based precautions, and thorough manual cleaning and disinfection. UV-C adds a validated supplementary layer that addresses the residual pathogen burden that manual methods inevitably leave behind.
For Canadian healthcare settings building or refining their IPAC programs, the 10 principles of infection control provides the foundational framework into which UV-C and other adjunctive technologies should be integrated.
Develop a formal UV-C implementation protocol that includes device selection criteria, room positioning guides, cycle time standards, documentation requirements, staff training, and regular equipment performance validation. Without this structure, even the best UV-C device will underperform.
Track outcomes. Monitor HAI rates in rooms and units where UV-C is deployed and compare trends over time. This data justifies the investment, identifies gaps, and supports continuous improvement.
As UV-C technology continues to evolve — with smarter robots, safer wavelengths, and better validation frameworks — its role in healthcare infection prevention will only grow. Facilities that understand both its power and its limitations today will be best positioned to deploy it effectively in the years ahead.
FAQs
Can UV-C replace manual cleaning in a healthcare facility?
No. UV-C is an adjunctive technology that supplements manual cleaning — it does not replace it. UV-C cannot penetrate organic matter or reach surfaces in shadow, which makes prior manual cleaning essential to its effectiveness.
Is UV-C safe to use in patient rooms while patients are present?
Conventional UV-C at 254 nm is not safe in occupied spaces. Rooms must be vacated during UV-C cycles. Far UV-C at 222 nm shows promise for use in occupied spaces and is currently under active research and regulatory review.
What pathogens does UV-C work best against?
UV-C is particularly effective against bacteria, including MRSA and C. difficile, and against respiratory viruses. Effectiveness varies by pathogen, UV-C dose, exposure time, and surface conditions.
Does UV-C need FDA or Health Canada clearance in Canada?
Regulatory requirements for UV-C devices used in healthcare are evolving. In the US, FDA clearance is now required for whole-room UV-C devices. In Canada, verify Health Canada medical device licensing requirements before purchasing and deploying UV-C technology in clinical settings.
How do I know if my UV-C device is working properly?
Devices should be validated at installation and tested regularly using dosimetry badges or biological indicators placed at key positions within the room. Manufacturer guidance on performance testing and maintenance schedules must be followed consistently.